NancyLouiseSicotteMD

Professor, Neurology, Cedars-Sinai

Dr. Sicotte is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
127 S San Vicente Blvd
Los Angeles, CA 90048
Phone+1 310-423-6472

Fax+1 310-423-0148

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1993 - 1996
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1992 - 1993
University of California, Irvine, School of MedicineClass of 1992

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com

Online Program to Reduce Depression in MS Start of enrollment: 2017 Feb 15
Active, not recruiting
Not Applicable
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis Start of enrollment: 2020 Jun 11
ACTIVE_NOT_RECRUITING

PubMed

Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis.
A R Manning, V Letchuman, M L Martin, E Gombos, T Robert-Fitzgerald
AJNR. American Journal of Neuroradiology. 2025-03-04
Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter Study.
Melissa Lynne Martin, Quy Cao, Elaina Luskin, Brian Renner, Lynn Daboul
Journal of Neuroimaging. 2025-01-22
Incorporation of the central vein sign into the McDonald criteria.
Moein Amin, Kunio Nakamura, Lynn Daboul, Carly O'Donnell, Quy Cao
Multiple Sclerosis and Related Disorders. 2025-01-01

Journal Articles

Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Tanuja Chitnis, Nancy L Sicotte, JAMA Neurology

Stopping DMTs in Older MS Patients: What the Data ShowMarch 3rd, 2025
Cedars-Sinai Designated a Center of Excellence in Rare Neuroimmune DisordersFebruary 4th, 2025
Cedars-Sinai Selected as Specialized Center of Care for Patients with Rare Movement DisordersOctober 2nd, 2024
Join now to see all

Central Vein Sign: A Diagnostic Biomarker in Multiple SclerosisCLEVELAND CLINIC LERNER COM-CWRU2020–2025
Central Vein Sign: A Diagnostic Biomarker in Multiple SclerosisCLEVELAND CLINIC LERNER COM-CWRU2020–2025
Hippocampal Volume Loss In Multiple Sclerosis: Clinical ConsequencesNational Center For Research Resources2008–2011
MS StudyNational Center For Research Resources2008–2010
Onset Of Progressive MS Structural &Functional DeterminantsNational Center For Research Resources2005–2010
Functional Organization Of Human Primary Motor CortexNational Center For Research Resources1998–2005
Onset Of Progressive MS Structure/Function DeterminantsNational Center For Research Resources2004
Funcational Organization Of Human Primary Motor CortexNational Institute Of Neurological Disorders And Stroke1998–2001